GLP-1 agonist Wegovy (semaglutide) brought in DKK 17.3 billion ($2.49 billion) in the period, restoring earlier levels of ...
Barron's on MSN54m
Novo Nordisk Earnings Are Soon. It’s All About Weight-Loss Drug Sales.Novo Nordisk posted solid quarterly results Wednesday before the market open.Sales came in at 71.3 billion Danish crowns ($10 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback